Agenda Details

Companion animals, primarily dogs, have been historically used in translational genetic disease models to successfully advance gene therapies for human medicine. More recently there is a clear recognition that specific chronic and metabolic diseases in middle-aged and geriatric dogs and cats, and even reproductive fertility in younger pets, can be addressed through novel, AAV-based gene therapies. Gene therapy in dogs and cats is a burgeoning area with commercial potential that faces similar as well as unique manufacturing and regulatory challenges versus human gene therapy. This distinctive workshop will introduce the audience to the exciting new world of veterinary medicine gene therapy drug devlopment. This session is partnered with the Michaelson Found Animals organization.